| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/02/2004 | CN1151793C Medicinal composition for treating osseous lesion in multiple myeloma |
| 06/02/2004 | CN1151792C Use of anti-oestrogens in preparation of drugs of male contraceptives |
| 06/02/2004 | CN1151791C Sustained-release composition containing cefaclor |
| 06/02/2004 | CN1151790C Agent for use in transplantation |
| 06/02/2004 | CN1151789C Use of aryl (or heteroaryl) pyrrolyl methanol derivatives |
| 06/02/2004 | CN1151788C Carbediolo-galenics |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/02/2004 | CN1151786C Treating urinary incontinence using (s)-oxybutynin and (s) -desethyloxybutynin |
| 06/02/2004 | CN1151785C Pharmaceutical composition comprising combination of metformin and fibrate, and its use in preparation of medicine for hyperglycemia |
| 06/02/2004 | CN1151784C Quick absorption liquid composition |
| 06/02/2004 | CN1151783C Delayed-release dosage forms of sertraline |
| 06/02/2004 | CN1151782C Medicinal injection liquid of anaesthesia induction and keeping and sedation of mammalian |
| 06/02/2004 | CN1151781C Use of nitric oxide donors or nitric oxide inhibitors for regulation of cervical dilatation and extensibility |
| 06/02/2004 | CN1151778C Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative |
| 06/02/2004 | CN1151777C Preparation for transport of active substance across barriers |
| 06/02/2004 | CN1151776C Clear hydroalcoholic multivitamin solution containing physiologically effective amounts of beta-carotene |
| 06/02/2004 | CN1151775C Method of treating dry eye disease with purinergic receptor agonists |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743954 Therapy for vision defects |
| 06/01/2004 | US6743953 Process for the preparation of xanthophyll crystals |
| 06/01/2004 | US6743941 Process for the production of piperidine derivatives |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743930 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and thereof |
| 06/01/2004 | US6743929 Amino and n-amino protected epoxide intermediates |
| 06/01/2004 | US6743919 2-aroylimidazole compounds for treating cancer |
| 06/01/2004 | US6743918 Process for producing camptothecin |
| 06/01/2004 | US6743913 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and α-1-blocking action |
| 06/01/2004 | US6743882 Functionalized silicon compound for use in the treatment of glass |
| 06/01/2004 | US6743827 Method for preparing colloidal solution of bismuth sodium tartrate |
| 06/01/2004 | US6743826 Delivery of compounds having poor water solubility; binding affinity to plasma proteins by way of non-covalent bonds; serum albumin and gamma globulin; paclitaxel, amphotericin b, camptothecin, carbamazepine, cyclosporin a; propofol |
| 06/01/2004 | US6743824 Administering selegiline to patient in an amount sufficient to prevent, reduce or eliminate one or more of the symptoms associated with peripheral neuropathy |
| 06/01/2004 | US6743822 Applying to area of skin a dermatologically acceptable composition comprising alpha -difluoromethylornithine in an amount effective to reduce hair growth |
| 06/01/2004 | US6743821 Controlling blood glucose concentration |
| 06/01/2004 | US6743818 Treating anxiety, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse, cognitive disorders, psychoses, depression and mood disorders |
| 06/01/2004 | US6743817 Substituted fused pyrroleimines and pyrazoleimines |
| 06/01/2004 | US6743816 Imidazole derivatives with anti-inflammatory activity |
| 06/01/2004 | US6743815 Estrogen receptor modulators |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743811 Oxazalidinone compounds and methods of preparation and use thereof |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743809 Indole Derivatives useful for the treatment of CNS disorders |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743806 Tetrazolylalkoxy-dihydrocarbostyril compound; treatment of an acute cerebral infarction; 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-substituted-2-quinolinone derivatives |
| 06/01/2004 | US6743805 Treating vascular proliferative disorders |
| 06/01/2004 | US6743804 Quinoline derivatives as NK3 antagonists |
| 06/01/2004 | US6743803 Medicines for the prevention and treatment of neurodegenerative diseases |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743801 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743799 Use of PDE V inhibitors for improved fecundity in mammals |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 06/01/2004 | US6743797 Administering to a mammal such as a human, an effective amount of vanoxerine or a salt, derivative or metabolite for treating cardiac arrhythmia |
| 06/01/2004 | US6743795 Inhibitors for hepatitis b and acquired immune deficiency syndrome (aids) because they interfere with removal of rna strand from rna-dna hybrid formed during the reverse transcription of viral rna to dna |
| 06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
| 06/01/2004 | US6743792 Antiinflammatory agents |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 06/01/2004 | US6743789 Substituted imidazo[1,5-a][1,2,4]triazolo[4,3-d][1,4]benzodiazepine derivatives |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743786 Vanadium compounds for treating cancer |
| 06/01/2004 | US6743784 Triarylethanes for treating symptoms, diseases and conditions in extra-reproductive tract tissues, such as osteopenia, that are responsive to treatment with estrogen |
| 06/01/2004 | US6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | US6743771 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating alzheimer's disease or creutzfelds-jakob disease for example |
| 06/01/2004 | US6743607 Production of complex carbohydrates |
| 06/01/2004 | US6743448 Fineness particle size; hormone replacement therapy |
| 06/01/2004 | US6743443 Tablets immediately disintegrating in the oral cavity |
| 06/01/2004 | US6743442 Bioavailability; sustained release |
| 06/01/2004 | US6743441 Controlling concentration; side effect reduction |
| 06/01/2004 | US6743440 Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals |
| 06/01/2004 | US6743437 Implant device with a retinoid for improved biocompatibility |
| 06/01/2004 | US6743436 Anesthetic composition for intravenous injection comprising propofol |
| 06/01/2004 | US6743434 Composition suitable for conditioning keratinous substrate comprising panthenol, citric acid, water, and water soluble source of bicarbonate; liquid crystal |
| 06/01/2004 | US6743433 Treatment of acne using alkanolamine compositions |
| 06/01/2004 | US6743417 Topical applying to nails |
| 06/01/2004 | US6743415 Delivery of anti-migraine compounds through an inhalation route |
| 06/01/2004 | US6743414 Bone disorders; osteoporosis |
| 06/01/2004 | US6743413 Suspension aerosol formulations |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 06/01/2004 | US6743191 Hemofiltration; solution containing ions of dihydrogen phosphate, sodium, calcium, magnesium, potassium, acetate and chloride and glucose |
| 06/01/2004 | US6742646 Systems, methods and apparatuses for manufacturing dosage forms |
| 06/01/2004 | CA2321542C Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated "agelagalastatin" |
| 06/01/2004 | CA2315871C Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 06/01/2004 | CA2295108C Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 06/01/2004 | CA2293336C Methods of using isomer enriched conjugated linoleic acid compositions |
| 06/01/2004 | CA2289648C Conjugated linoleic acid compositions |
| 06/01/2004 | CA2279943C Treatment of skin disorders |
| 06/01/2004 | CA2270004C Stable mitoxantrone solutions |
| 06/01/2004 | CA2266016C Tricyclic inhibitors of farnesyl protein transferase |
| 06/01/2004 | CA2196922C Pharmaceutically stable oxaliplatinum preparation |
| 06/01/2004 | CA2190993C Protective agent for organ or tissue |
| 06/01/2004 | CA2146646C Benzopyranones, method of preparing them and their use |
| 06/01/2004 | CA2118219C Preparations of low molecular weight hyaluronic acid for stimulating bone formation |
| 06/01/2004 | CA2107669C Preparation for treating wounds and hemorrhoides |
| 06/01/2004 | CA2092505C Pharmaceutical compositions containing l-carnitine or an acyl l-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders |
| 05/27/2004 | WO2004044818A1 System and method for generating an amalgamated database |
| 05/27/2004 | WO2004044235A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) |
| 05/27/2004 | WO2004044219A2 Xanthene compounds for cancer chemotherapy |
| 05/27/2004 | WO2004044199A1 Screening method |
| 05/27/2004 | WO2004044194A2 Calmodulin independent activation of nitric oxide synthase by nadph analogs |